Search research articles
Contact Us
Filters
Showing results (61-70 of 91) with videos related to
Page
of 10
Sort By:
Experimental Neurology
|
May 19, 2001
Striatal cannabinoid CB1 receptor mRNA expression is decreased in the reserpine-treated rat model of Parkinson's disease
M A Silverdale, S McGuire, A McInnes, et al.
British Journal of Neurosurgery
|
January 1, 1992
Subthalamic nucleotomy alleviates parkinsonism in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-exposed primate
T Z Aziz, D Peggs, E Agarwal, et al.
Movement Disorders : Official Journal of the Movement Disorder Society
|
September 24, 1999
The alpha2-adrenergic receptor antagonist idazoxan reduces dyskinesia and enhances anti-parkinsonian actions of L-dopa in the MPTP-lesioned primate model of Parkinson's disease
B Henry, S H Fox, D Peggs, et al.
Movement Disorders : Official Journal of the Movement Disorder Society
|
January 1, 1992
Regional changes in 2-deoxyglucose uptake associated with neuroleptic-induced tardive dyskinesia in the Cebus monkey
I J Mitchell, A R Crossman, U Liminga, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology
|
July 6, 2000
Enhanced levels of endogenous cannabinoids in the globus pallidus are associated with a reduction in movement in an animal model of Parkinson's disease
V Di Marzo, M P Hill, T Bisogno, et al.
Neuroscience
|
July 1, 1986
A semi-quantitative atlas of 5-hydroxytryptamine-1 receptors in the primate brain
A M Stuart, I J Mitchell, P Slater, et al.
Journal of the Neurological Sciences
|
May 1, 1989
Drug-induced dyskinesia in primates rendered hemiparkinsonian by intracarotid administration of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)
C E Clarke, S Boyce, R G Robertson, et al.
Journal of Receptor Research
|
January 1, 1987
Autoradiographic analysis of [3H]kainic acid binding in primate brain
A J Cross, W J Skan, P Slater, et al.
The Canadian Journal of Neurological Sciences. Le Journal Canadien Des Sciences Neurologiques
|
August 1, 1987
MPTP-induced parkinsonism in the monkey: neurochemical pathology, complications of treatment and pathophysiological mechanisms
A R Crossman, C E Clarke, S Boyce, et al.
AJNR. American Journal of Neuroradiology
|
October 31, 2009
Anatomic localization of dyskinesia in children with "profound" perinatal hypoxic-ischemic injury
P D Griffiths, M R Radon, A R Crossman, et al.
Page
of 10
Search research articles
Search
Showing results (61-70 of 91) with videos related to
Sort By:
Page
of 10
Experimental Neurology
|
May 19, 2001
Striatal cannabinoid CB1 receptor mRNA expression is decreased in the reserpine-treated rat model of Parkinson's disease
M A Silverdale, S McGuire, A McInnes, et al.
British Journal of Neurosurgery
|
January 1, 1992
Subthalamic nucleotomy alleviates parkinsonism in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-exposed primate
T Z Aziz, D Peggs, E Agarwal, et al.
Movement Disorders : Official Journal of the Movement Disorder Society
|
September 24, 1999
The alpha2-adrenergic receptor antagonist idazoxan reduces dyskinesia and enhances anti-parkinsonian actions of L-dopa in the MPTP-lesioned primate model of Parkinson's disease
B Henry, S H Fox, D Peggs, et al.
Movement Disorders : Official Journal of the Movement Disorder Society
|
January 1, 1992
Regional changes in 2-deoxyglucose uptake associated with neuroleptic-induced tardive dyskinesia in the Cebus monkey
I J Mitchell, A R Crossman, U Liminga, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology
|
July 6, 2000
Enhanced levels of endogenous cannabinoids in the globus pallidus are associated with a reduction in movement in an animal model of Parkinson's disease
V Di Marzo, M P Hill, T Bisogno, et al.
Neuroscience
|
July 1, 1986
A semi-quantitative atlas of 5-hydroxytryptamine-1 receptors in the primate brain
A M Stuart, I J Mitchell, P Slater, et al.
Journal of the Neurological Sciences
|
May 1, 1989
Drug-induced dyskinesia in primates rendered hemiparkinsonian by intracarotid administration of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)
C E Clarke, S Boyce, R G Robertson, et al.
Journal of Receptor Research
|
January 1, 1987
Autoradiographic analysis of [3H]kainic acid binding in primate brain
A J Cross, W J Skan, P Slater, et al.
The Canadian Journal of Neurological Sciences. Le Journal Canadien Des Sciences Neurologiques
|
August 1, 1987
MPTP-induced parkinsonism in the monkey: neurochemical pathology, complications of treatment and pathophysiological mechanisms
A R Crossman, C E Clarke, S Boyce, et al.
AJNR. American Journal of Neuroradiology
|
October 31, 2009
Anatomic localization of dyskinesia in children with "profound" perinatal hypoxic-ischemic injury
P D Griffiths, M R Radon, A R Crossman, et al.
Page
of 10